:   free English Wikipedia <ref>{{Cite pmid|17902129}}</ref> Nephropedia Template TP ( {{tp|p=17902129|t=Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases |pdf=|usr=|}} Twit Text Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases http://www.kidney.de/pget.php?&tw=1&pmid=17902129 DeepDyve Pubget Overpricing

lüll Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases Norvell JP; Blei AT; Jovanovic BD; Levitsky J Liver Transpl 2007[Oct]; 13 (10): 1428-34 Hepatitis is a rare complication of herpes simplex virus (HSV), often leading to acute liver failure (ALF), liver transplantation (LT), and/or death. Our aim was to identify variables associated with either survival or progression (death/LT), based on an analysis of cases in the literature and our institution. A total of 137 cases (132 literature, 5 institutional) of HSV hepatitis were identified. The main features at clinical presentation were fever (98%), coagulopathy (84%), and encephalopathy (80%). Rash was seen in less than half of patients. Most cases (58%) were first diagnosed at autopsy and the diagnosis was suspected clinically prior to tissue confirmation in only 23%. Overall, 74% of cases progressed to death or LT, with 51% in acyclovir-treated patients as compared to 88% in the untreated subjects (P=0.03). Variables on presentation associated with death or need for LT compared to spontaneous survival: male gender, age>40 yr, immunocompromised state, ALT>5,000 U/L, platelet count<75x10(3)/L, coagulopathy, encephalopathy, and absence of antiviral therapy. In conclusion, HSV hepatitis has a high mortality and is often clinically unsuspected. Patients who are male, older, immunocompromised, and/or presenting with significant liver dysfunction are more likely to progress to death and should thus be evaluated for LT early. Based on the frequent delay in HSV diagnosis, low risk-benefit ratio, and significantly improved outcomes, empiric acyclovir therapy for patients presenting with ALF of unknown etiology is recommended until HSV hepatitis is excluded. |*Periodicals as Topic[MESH] |Adult[MESH] |Female[MESH] |Hepatitis, Viral, Human/complications/epidemiology/*virology[MESH] |Humans[MESH] |Incidence[MESH] |Liver Failure, Acute/epidemiology/*etiology/surgery[MESH] |Liver Transplantation/statistics & numerical data[MESH] |Male[MESH] |Middle Aged[MESH] |Retrospective Studies[MESH] |Survival Rate/trends[MESH]

*{{pmid17902129}}
*<b>[http://www.kidney.de/mlpefetch.php?search=17902129 Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases ]</b> Liver Transpl 2007; 13(10) ; 1428-34 Norvell JP; Blei AT; Jovanovic BD; Levitsky J

    *17902129*

Nephropedia PMID record
{{recpmid|pmid=17902129|ti=Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases |au=Norvell JP; Blei AT; Jovanovic BD; Levitsky J|so=Liver Transpl 2007; 13 (10): 1428-34|ab=Hepatitis is a rare complication of herpes simplex virus (HSV), often leading to acute liver failure (ALF), liver transplantation (LT), and/or death. Our aim was to identify variables associated with either survival or progression (death/LT), based on an analysis of cases in the literature and our institution. A total of 137 cases (132 literature, 5 institutional) of HSV hepatitis were identified. The main features at clinical presentation were fever (98%), coagulopathy (84%), and encephalopathy (80%). Rash was seen in less than half of patients. Most cases (58%) were first diagnosed at autopsy and the diagnosis was suspected clinically prior to tissue confirmation in only 23%. Overall, 74% of cases progressed to death or LT, with 51% in acyclovir-treated patients as compared to 88% in the untreated subjects (P=0.03). Variables on presentation associated with death or need for LT compared to spontaneous survival: male gender, age>40 yr, immunocompromised state, ALT>5,000 U/L, platelet count<75x10(3)/L, coagulopathy, encephalopathy, and absence of antiviral therapy. In conclusion, HSV hepatitis has a high mortality and is often clinically unsuspected. Patients who are male, older, immunocompromised, and/or presenting with significant liver dysfunction are more likely to progress to death and should thus be evaluated for LT early. Based on the frequent delay in HSV diagnosis, low risk-benefit ratio, and significantly improved outcomes, empiric acyclovir therapy for patients presenting with ALF of unknown etiology is recommended until HSV hepatitis is excluded.}}
Deutsche Wikipedia - im Artikel
<ref>{{BibPMID|17902129}}</ref>
Hier den unten stehenden Textblock hineinkopieren
{{BibRecord | Autor = Norvell JP; Blei AT; Jovanovic BD; Levitsky J | Titel = Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases | Band = 13 | Nummer = 10 | Jahr = 2007 | Monat = Oct | Sprache = eng | DOI = | Seite = 1428-34 | PMID = 17902129 | Typ= {{{Typ|}}} | Kommentar = {{{Kommentar|}}} | format = {{{format|}}} | record = {{{record|}}} }}

Liver Transpl